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Abstract
Diabetes is a frequent underlying medical condition among individuals with Staphylococcus aureus infections, and diabetic
patients often suffer from chronic inflammation and prolonged infections. Neutrophils are the most abundant inflammatory
cells during the early stages of bacterial diseases, and previous studies have reported deficiencies in neutrophil function in
diabetic hosts. We challenged age-matched hyperglycemic and normoglycemic NOD mice intraperitoneally with S. aureus
and evaluated the fate of neutrophils recruited to the peritoneal cavity. Neutrophils were more abundant in the peritoneal
fluids of infected diabetic mice by 48 h after bacterial inoculation, and they showed prolonged viability ex vivo compared to
neutrophils from infected nondiabetic mice. These differences correlated with reduced apoptosis of neutrophils from
diabetic mice and were dependent upon the presence of S. aureus and a functional neutrophil respiratory burst. Decreased
apoptosis correlated with impaired clearance of neutrophils by macrophages both in vitro and in vivo and prolonged
production of proinflammatory tumor necrosis factor alpha by neutrophils from diabetic mice. Our results suggest that
defects in neutrophil apoptosis may contribute to the chronic inflammation and the inability to clear staphylococcal
infections observed in diabetic patients.
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Introduction
Diabetes mellitus is a group of metabolic disorders characterized
by hyperglycemia. Patients with type 1 diabetes fail to produce
insulin, and patients with type 2 diabetes develop resistance to
insulin. The incidence of diabetes mellitus continues to rise,
especially in developed countries [1,2]. While the prevalence of
diabetes currently lies between 6% and 10%, it is estimated that
individuals born in the United States in the year 2000 have a risk
of 1 in 3 to develop diabetes during their lifetime [3]. Although
type 1 and type 2 diabetes differ in their respective etiologies, both
forms share complications such as vasculopathy, nephropathy,
retinopathy and neuropathy. Additionally, diabetes is associated
with deficiencies in wound healing, chronic inflammation and
enhanced susceptibility to infection. Diabetic foot infections are a
major complication of diabetes mellitus [4], and chronic leg ulcers
are a frequent cause for hospitalizations and amputations among
diabetic patients. Staphylococcus aureus is a bacterial pathogen
frequently implicated in these chronic infections. S. aureus nasal
carriage, a known risk factor for staphylococcal disease, is higher
among diabetic patients than healthy individuals [5,6]. Invasive
staphylococcal infections (such as endocarditis or bacteremia) are
more prevalent in diabetic than in nondiabetic patients and are
associated with a poor outcome in patients with diabetes [7,8]. In
studies of diabetic rodents, chronic wounds were characterized by
tissue persistence of inflammatory cells, such as neutrophils [9,10],
and prolonged expression of proinflammatory cytokines [11].
Whereas some authors report impaired bactericidal function and
decreased phagocytic activity by neutrophils from diabetic patients
[12,13], others have failed to demonstrate significant differences in
neutrophil function in diabetic versus control patients [14]. Some
of these conflicting findings may be explained by heterogeneous
patient populations. Animal models of diabetes offer the advantage
of examining the function and fate of neutrophils in defined
models of infections [15–17].
Neutrophils are short-lived but abundant leukocytes. They are
rapidly recruited to the site of a bacterial infection and are
generally considered to be part of the ‘‘first line of defense’’ of the
host innate immune system. Because of their sheer numbers, as
well as their toxic contents and elaboration of proinflammatory
cytokines, neutrophil clearance is key to the resolution of the
inflammatory response and hence tightly regulated [18,19].
Neutrophil apoptosis (either spontaneous or pathogen induced) is
crucial for neutrophil uptake and subsequent elimination by
macrophages at the site of infection, leading to resolution of the
inflammatory process [20]. To address whether dysregulated
neutrophil apoptosis during S. aureus infection might contribute to
the severity and chronicity of bacterial infections observed in
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23633diabetic patients, we utilized a mouse model of invasive S. aureus
infection in a diabetic host.
Methods
Ethics Statement
Animal experiments were performed in accordance with the
guidelines of the Harvard Medical School Standing Committee on
Animals (Animal Welfare Assurance Number A3431-01) under
approved protocol 03565. The Harvard Medical School animal
management program is accredited by the American Association
for Accreditation of Laboratory Animal Care and meets National
Institutes of Health standards as set forth in ‘‘Guide for the Care
and Use of Laboratory Animals’’ (DHSS Publication No. (NIH)
85-23 Revised 1985). The institution also accepts as mandatory
the Public Health Service ‘‘Policy on Humane Care and Use of
Laboratory Animals by Awardee Institutions’’ and NIH ‘‘Princi-
ples for the Utilization and Care of Vertebrate Animals Used in
Testing, Research and Training.’’
Mouse model of S. aureus infection
NOD mice were derived by Makino et al. [15] by selective
inbreeding of a single female glucosuric mouse from a substrain of
ICR mice. Female NOD mice spontaneously develop type 1
diabetes between 15 and 30 weeks of age [16], and by 20 weeks of
age, 70–80% of females become diabetic. We obtained NOD mice
from The Jackson Laboratories (Bar Harbor, ME), and some of
the animals were bred in our facility. The mice were housed in a
modified barrier facility under viral antibody-free conditions and
were fed an autoclaved diet. Blood glucose levels were tested with
glucostrips (Bayer, Elkhart, IN), and blood ketone levels were
tested with PrecisionXtra b-Ketone Test strips (Abbott Laborato-
ries, Alameda, CA). Nondiabetic mice were normoglycemic with
blood glucose levels below 125 mg/dl (7 mmol/l). Diabetic mice
had negative or low blood acetone levels, normal body weight, and
blood glycemia levels $450 mg/dl (25 mmol/l) at the time of
bacterial challenge.
Female diabetic (age 13–25 weeks) mice and control age-
matched nondiabetic female littermates were challenged intraper-
itoneally (IP) with 10
8 CFU S. aureus strain PS80 (a capsular
serotype 8 isolate) cultured overnight on Columbia salt agar, and
the animals were euthanized thereafter at the indicated time
points. The peritoneal cavity was lavaged with 5 ml PBS, the total
inflammatory cells were harvested, and a differential cell count
determined. The S. aureus CFU/ml peritoneal fluid was deter-
mined by quantitative plate counts.
Neutrophil isolation and ex vivo incubation
Neutrophils were isolated from peritoneal exudates of S. aureus-
infected diabetic and nondiabetic mice by density gradient
centrifugation. Peritoneal lavage fluids were overlaid on a 62%
Percoll gradient and centrifuged for 25 min at 1200 g at room
temperature. Contaminating erythrocytes were removed by
hypotonic lysis. After two additional washes in PBS, viable
neutrophils were enumerated by trypan blue exclusion, suspended
in Minimum Essential Medium (MEM) supplemented with 10%
fetal calf serum (FCS) and 100 ug/ml gentamicin (Gm) to prevent
extracellular bacterial growth and incubated ex vivo. Neutrophil
viability and apoptosis were measured at time zero and after 6 or
12 h of incubation at 37uC.
Alternatively, neutrophils were recruited to the mouse perito-
neal cavity by IP injection of 1 ml of a 9% casein solution as a
sterile inflammatory stimulus 18 h and again 3 h before
euthanasia. Where indicated, neutrophils were stimulated ex vivo
with S. aureus (pre-opsonized for 20 min with normal mouse serum
stored at 280uC to preserve complement activity) at a bacterium
to cell ratio of 1:1 or 5:1. After an incubation time of 1 h at 37uC,
the neutrophils were washed, resuspended in MEM/FCS with
100 mg/ml Gm and further incubated at 37uC for 6 or 18 h.
Apoptosis assays
Neutrophil apoptosis was assessed by three methods. Phospha-
tidylserine exposure on the outer cell membrane was measured
using an annexin binding assay (BD Biosciences, San Jose, CA)
according to the manufacturer’s instructions. In brief, 1.5610
5
neutrophils were washed, resuspended in 100 ml PBS and labeled
with PE-labeled Ly6G antibody (eBioscience, San Diego, CA) for
15 min on ice. After washing away unbound antibodies, cells were
resuspended in 100 ml binding buffer, 5 ml FITC labeled annexin
V and 5 ml 7-amino-actinomycin D (AAD) to exclude dead cells.
After incubation for 20 min in the dark, the percentage of
annexin(+), AAD(2), Ly6G(+) cells was analyzed by flow
cytometry (BD FACSCaliburH). Nuclear condensation was
measured by suspending neutrophils in PBS and air drying them
on a microscope slide. Cells were stained for 10 min with 10 mg/
ml Hoechst 33342 (Invitrogen, Carlsbad, CA), mounted in PBS/
glycerol, and at least 200 cells were counted using fluorescence
microscopy. Cells with condensed and fragmented nuclei were
scored as apoptotic. DNA strand breaks were assessed with a
TUNEL staining procedure (Roche Applied Science, Indianapolis,
IN). In brief, 2610
5 neutrophils were fixed in cold paraformal-
dehyde, washed in PBS and permeabilized overnight in cold 70%
ethanol in PBS. The neutrophils were washed in TUNEL dilution
buffer, labeled with TUNEL reaction mix according to the
manufacturer’s protocol, washed and incubated with PE-labeled
Ly6G antibodies. The percentage of TUNEL(+), Ly6G(+) cells was
assessed by flow cytometry.
Intracellular tumor necrosis factor alpha (TNFa) staining
Neutrophils were isolated as described above from the
peritoneal lavage fluids of diabetic or nondiabetic mice 18 h after
IP challenge with S. aureus. The cells were washed, suspended in
MEM/FCS + 100 mg/ml Gm, and incubated for 3 h with
Brefeldin A (1 ng/ml; GolgiPlugH, BD Biosciences). Alternatively,
the isolated neutrophils were incubated ex vivo for 7 h at 37uC
before a 3-h Brefeldin A treatment (leading to total incubation
time of 10 h). TNFa production was measured using an
intracellular cytokine staining procedure. The neutrophils were
washed, fixed in 4% paraformaldehyde for 20 min, pelleted and
resuspended in PBS/FCS for overnight storage at 4uC. After an
additional wash, the neutrophils were suspended in Wash/Perm
buffer (BD Biosciences) and labeled with FITC-labeled Ly6G and
PE-labeled mouse TNFa antibodies (both eBioscience). After two
washes, the neutrophils were suspended in PBS, and the
percentage of Ly6G(+) TNFa (+) cells was determined by flow
cytometry.
Phagocytosis of neutrophils by macrophages – in vitro
Neutrophils isolated from peritoneal exudates of S. aureus-
infected mice were labeled with CellTrackerH Green (Invitrogen)
for 15 min, washed, resuspended in MEM containing 100 mg/ml
Gm, and incubated for 8 h at 37uC to induce apoptosis.
Macrophages from the mononuclear fraction of the same exudates
were adhered to glass cover slips in tissue culture plates at a
concentration of 3610
5 cells/well, and nonadherent cells were
washed away after 90 min. After a total incubation time of 8 h,
adherent macrophages were overlaid with 3610
6 labeled neutro-
phils, incubated for 2 h and then washed thoroughly with PBS.
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Orange (Invitrogen), washed and fixed in paraformaldehyde.
Slides were mounted in antifade solution (50% glycerol in PBS
with 2% n-propyl-gallate) and examined by fluorescence micros-
copy. The percentage of macrophages with internalized neutro-
phils was calculated from a minimum of 200 cells counted.
Phagocytosis of neutrophils by macrophages – in vivo
Neutrophils purified from peritoneal exudates of S. aureus-
infected diabetic or nondiabetic mice were labeled for 15 min with
CellTrackerH Green, washed, and suspended in PBS. The labeled
neutrophils (2610
6 neutrophils per mouse) were injected IP into
diabetic or nondiabetic mice infected with 10
8 CFU S. aureus for
20 h. Peritoneal exudates were recovered from the recipient
animals 3 h later, and the mononuclear cells were purified,
washed, and labeled with PE-labeled F4/80 antibodies
(eBioscience). The cells were fixed in paraformaldehyde, and the
percentage of macrophage-associated (F4/80+) CellTracker Green
labeled neutrophils was determined by flow cytometry.
Statistical analysis
Results were expressed as means 6 standard error of the mean
(SEM), and Shapiro-Wilk tests were used to verify the assumption
of a normally distributed data set. The data shown in Figs. 1 and 2
were analyzed by the unpaired Student t test. However, in all
subsequent experiments each mouse was compared individually to
an age-matched normoglycemic littermate since NOD mice
developed diabetes between 13 and 25 weeks of age, . As a result,
data sets comparing age-matched diabetic and nondiabetic mice
were analyzed with a two-tailed paired Student t test. A P-value of
,0.05 was considered to be statistically significant.
Results
Systemic model of S. aureus infection in nondiabetic and
diabetic mice
Our previous studies revealed that a localized S. aureus PS80
infection of the hindpaw tissues was exacerbated in diabetic NOD
mice compared to that of nondiabetic mice, and the diabetic
animals were unable to clear the infection over a 10-day period.
We observed delayed neutrophil recruitment to the site of
infection in the diabetic mice, and this finding was consistent
with chemokine levels in the infected hindpaw tissues of the
diabetic mice that were significantly lower than those of age-
matched nondiabetic littermates [17]. In this study age-matched
nondiabetic or diabetic mice were challenged IP with 10
8 CFU S.
aureus PS80. All the mice developed a nonlethal acute peritonitis
and were bacteremic. The diabetic mice showed impaired
clearance of the systemic infection compared to the nondiabetic
mice, who cleared the peritoneal infection within 5 days (Fig. 1).
To determine whether the delayed clearance of S. aureus from
the peritoneal cavity and blood of diabetic mice was due to an
impaired inflammatory response, we measured the numbers of
total leukocytes recruited to the peritoneal cavity at various time
points following S. aureus challenge. The total cell number in the
peritoneal lavage fluid was increased from ,10
6 to 10
7 cells/ml
peritoneal fluid in both diabetic and nondiabetic mice after S.
aureus inoculation, and the kinetics of cell migration were similar in
both groups (Fig. 2A). Diabetic animals showed an increased
bacterial burden at the early time points (,24 h post bacterial
challenge), but no delay in neutrophil recruitment to the peritoneal
cavity was observed (Fig. 2B). Diabetic mice showed significantly
higher neutrophil counts in the peritoneal cavity 48 h and 120 h
after challenge with S. aureus (Fig. 2). Overall, the percentage of
each cell type - neutrophils, macrophages, and lymphocytes -
recruited to the peritoneal cavity was similar in diabetic and
nondiabetic animals.
Enhanced viability of diabetic neutrophils
In an attempt to explain the failure of diabetic mice to clear the
staphylococcal infection despite an apparently adequate inflam-
matory response, we assessed the bactericidal activity of neutro-
phils recruited to the peritoneal cavity following the administration
of a sterile inflammatory stimulus (casein). No difference in killing
capacity between the two mouse groups was apparent, since
neutrophils from diabetic and nondiabetic mice killed 65–70% of
opsonized S. aureus within 1 h ex vivo.
Because the neutrophils recruited to the peritoneal cavity of
diabetic mice appeared functionally intact, we hypothesized that
they might show impaired clearance from the infection site, and
that this finding might correlate with the persistent inflammation
observed in diabetic hosts. To test neutrophil viability without
interference by variable bacterial numbers recovered in vivo,w e
isolated neutrophils from mouse peritoneal exudates 18 h after
challenge with S. aureus, i.e. at a time point where bacterial loads in
the peritoneal cavity were similar in diabetic and nondiabetic
animals and similar numbers of neutrophils were recovered from
the peritoneal lavage fluids. The neutrophils were incubated for
either 6 or 12 h ex vivo at 37uC, and cell viability was assessed
microscopically by trypan blue exclusion. Pair-wise comparisons
showed that 72% of neutrophils from diabetic mice remained
viable after 6 h compared with 63% of neutrophils from
nondiabetic mice (Fig. 3; P=0.039). This modest yet reproducible
difference in viability was abrogated by 12 h, when only ,30% of
neutrophils from either group of mice remained viable.
S. aureus induced apoptosis is reduced in neutrophils
from diabetic mice
Since neutrophil apoptosis is the main mode of cell death in
mature neutrophils, we set out to test whether delayed apoptosis
might contribute to the observed increase in the viability of
neutrophils from diabetic mice. Direct examination of peritoneal
exudate fluids revealed few apoptotic neutrophils, which may be
due to efficient in vivo clearance by macrophages. Neutrophils,
isolated 18 h after challenge with S. aureus, were subsequently
Figure 1. Diabetic mice show enhanced susceptibility to
systemic S. aureus infection. Age-matched nondiabetic (7) and
diabetic (,) mice were challenged IP with 10
8 CFU S. aureus PS80.
Results of quantitative cultures are shown as mean 6 SEM CFU/ml
peritoneal fluid recovered from 3–13 mice per group. * indicates
P,0.05 by the unpaired Student t test.
doi:10.1371/journal.pone.0023633.g001
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observed among the experimental animals, we tested age-matched
female diabetic and nondiabetic mice in pair-wise comparisons.
Phosphatidylserine exposure (annexin V binding), DNA strand
breaks (TUNEL staining) and nuclear condensation were
measured as different hallmarks of cellular apoptosis. Neutrophils
recovered from the peritoneal cavities of S. aureus infected diabetic
mice (without additional incubation) showed similar annexin
binding to neutrophils from control mice (15.963.4% versus
18.665.4%). However, upon further incubation ex vivo, neutro-
phils from diabetic mice bound significantly less annexin than
neutrophils from nondiabetic mice at 6 h (P=0.009) and 12 h
(P=0.0098) (Figs. 4A and 4D). Similarly, neutrophils from diabetic
mice showed reduced TUNEL staining 6 h after isolation
(P=0.049; Figs. 4B and 4D) compared to neutrophils from
diabetic mice. Nuclear condensation was likewise reduced at both
6h ( P=0.032) and 12 h (P=0.013) after isolation when
neutrophils from diabetic and nondiabetic mice were compared
(Figs. 4C and 4D). Together these results indicate that neutrophils
from diabetic mice show a significantly reduced rate of apoptosis
in response to S. aureus infection compared to neutrophils from
age-matched nondiabetic mice (Fig. 4D).
To address whether the differences in neutrophil apoptosis were
pathogen dependant or due to aberrant constitutive apoptosis, we
evaluated the fate of neutrophils recruited to the peritoneal cavity
following injection of casein. Neutrophils were isolated from
murine peritoneal exudates and incubated ex vivo with or without
pre-opsonized S. aureus. Spontaneous neutrophil apoptosis (as
measured by percent annexin-positive cells) was similar for
diabetic and nondiabetic mice at both 6 h (21.864.3% versus
Figure 2. Cellular kinetics of peritoneal fluids recovered from S. aureus infected mice. At different time points, animals were euthanized,
and peritoneal lavage fluids were collected. Total cell counts (A) were determined with a hemocytometer. For differential counts cytospin
preparations of peritoneal cells were stained with Diff-Quik, and neutrophils (B), macrophages (C), and lymphocytes (D) were enumerated. 7:
nondiabetic mice, ,: diabetic mice. * indicates P,0.05 by the unpaired Student t test.
doi:10.1371/journal.pone.0023633.g002
Figure 3. Viability of neutrophils isolated from the peritoneal
cavities of diabetic and nondiabetic mice infected for 18 h with
S. aureus PS80. Neutrophils were incubated ex vivo for 6 or 12 h, and
the percentage of viable (trypan blue negative) neutrophils was
measured. Mean percentages 6 SEM from five independent experi-
ments are depicted; * indicates P,0.05.
doi:10.1371/journal.pone.0023633.g003
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isolation. When opsonized S. aureus cells were added to the murine
neutrophil suspension at a multiplicity of infection (MOI) of 1,
apoptosis of neutrophils from diabetic or nondiabetic mice was
similar at 6 h (32.362.7% versus 37.062.7%). However,
significantly (P,0.01) fewer apoptotic cells were found among
neutrophils from diabetic animals than nondiabetic mice after
18 h (Fig. 5). Increasing the MOI to 5 led to noticeable differences
as early as 6 h after exposure to S. aureus with significantly
(P=0.012) fewer annexin-positive cells in the diabetic compared to
the nondiabetic sample. These results indicate that the decrease in
apoptosis characteristic of neutrophils from diabetic mice was
specific for neutrophils exposed to S. aureus.
We previously demonstrated that peripheral blood neutrophils
from diabetic mice showed a diminished respiratory burst upon
ingestion of S. aureus compared to neutrophils from nondiabetic
mice [17]. A functional NADPH-oxidase is essential for the
induction of apoptosis (as measured by phosphatidylserine expo-
sure) upon ingestion of S. aureus, and a lack of NADPH-oxidase
activity leads to elevated neutrophil numbers in the peritoneal
cavities of mice challenged with heat-killed staphylococci [21]. To
determine whether the reduced apoptosis observed in diabetic mice
was due to a lower oxidative burst in neutrophils from diabetic
animals, we incubated casein-elicited neutrophils from the perito-
neal cavities of diabetic or nondiabetic mice with opsonized S. aureus
in the presence or absence of diphenyleneiodonium (DPI), an
Figure 4. Neutrophil apoptosis—in vivo infection. Neutrophils were isolated from the peritoneal cavities of mice 18 h after IP challenge with
10
8 CFU S. aureus and evaluated immediately or after incubation ex vivo for 6 or 12 h. A) Representative flow cytometric analysis of annexin V binding
(A) or TUNEL staining (B) of Ly6G+ neutrophils from NOD mice that had been incubated ex vivo for 6 h. Black line represents unstained neutrophils.
(C) Nuclear condensation observed in neutrophils from a diabetic and a nondiabetic mouse 6 h after isolation. White arrows indicate condensed and
fragmented nuclei. (D) Quantitative comparison of annexin binding, TUNEL staining and nuclear condensation of neutrophils from age-matched
diabetic and nondiabetic animals reveals that neutrophils from diabetic mice show reduced apoptosis compared to neutrophils from nondiabetic
mice. Mean percent apoptotic cells 6 SEM from 4 to 6 independent experiments are depicted. P values are calculated from pair-wise comparisons of
age-matched mice; * indicates P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0023633.g004
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differences in neutrophil apoptosis (measured by annexin binding)
between diabetic and nondiabetic mice were reduced in the absence
of a functional NADPH oxidase enzyme, suggesting that differences
in the oxidative burst contribute to the reduced apoptosis of
neutrophils from diabetic animals infected with S. aureus.
Neutrophils from S. aureus infected diabetic mice fail to
down-regulate cytokine production
Kobayashi et al. demonstrated that the expression of proinflam-
matory cytokines by human neutrophils was down-regulated during
phagocytosis-induced apoptosis [22]. Failure to undergo apoptosis
may thus lead to prolonged production of these inflammatory
cytokines by neutrophils. To determine whether neutrophils from
diabetic mice might show prolonged cytokine production due to
delayed apoptosis, we measured intracellular TNFa (a representative
proinflammatory cytokine) inneutrophils isolated from the peritoneal
cavities of diabetic or nondiabetic mice 18 h after challenge with S.
aureus.A f t e rex vivo neutrophil aging, neutrophil expression of TNFa
was detected using an intracellular cytokine staining procedure.
Three hours after isolation, equivalent numbers of neutrophils from
diabetic and nondiabetic mice stained positive for TNFa (Fig. 6).
Whereas 55.867.7% of neutrophils from control animals were
TNFa-positive after 3 h, only 23.863.2% stained positive after 10 h
(P=.002). In contrast, no significant reduction in TNFa positive
neutrophils from diabetic mice occurred over time (50.568.3% at
3 h versus 43.265.7% at 10 h, P=.59). Consequently, significantly
(P=.036) more neutrophils from diabetic mice stained positive for
TNFa than neutrophils from nondiabetic mice after 10 h (Fig. 6).
Clearance of S. aureus stimulated neutrophils is reduced
in diabetic mice
Programmed cell death in neutrophils results in recognition,
uptake and clearance by macrophages [20]. To determine whether
neutrophil uptake and removal by macrophages differed between
diabetic and nondiabetic animals, we designed in vitro and in vivo
experiments. We isolated and labeled neutrophils recovered from
the peritoneal cavities of S. aureus-infected diabetic and nondiabetic
mice. For in vitro experiments, the neutrophils were aged for 8 h
and then incubated for 2 h with adherent autologous macrophag-
es. The macrophage cultures were washed, and cells with ingested
fluorescent neutrophils were counted by microscopy. Samples
from diabetic animals had significantly fewer macrophages with
ingested neutrophils than samples from nondiabetic controls
(8.460.3% versus 13.461.4%, P=0.028; Fig. 7).
Phagocytosis of apoptotic neutrophils by macrophages not only
depends on the recognition of apoptotic neutrophils by macro-
phage receptors but also on several serum derived factors [23]. To
validate our in vitro findings, we performed in vivo experiments
whereby we injected labeled donor neutrophils (isolated from
diabetic or nondiabetic mice 18 h after IP challenge with S. aureus)
into corresponding (i.e. diabetic or nondiabetic) recipient animals
24 h after IP challenge with S. aureus. Peritoneal cavities were
lavaged 3 h later, and the percentage of fluorescent neutrophils
that colocalized with macrophages was measured by flow
cytometry. Consistent with our in vitro data, diabetic animals
showed fewer labeled neutrophils (20.862.0%) associated with
macrophages than the nondiabetic control animals (30.563.6%;
P=0.026, Fig. 8).
Figure 5. Neutrophil apoptosis—ex vivo infection. Apoptosis of neutrophils isolated from mouse peritoneal cavities after injection of casein as a
sterile inflammatory stimulus. The cells were incubated ex vivo for 6 or 18 h with or without the addition of opsonized staphylococci. In the absence
of S. aureus, no significant differences in annexin binding were observed. However, at a S. aureus MOI of 1, significantly fewer neutrophils from
diabetic mice were apoptotic after 18 h; an MOI of 5 resulted in significant differences between the mouse groups by 6 h. No significant differences
between neutrophils from diabetic and nondiabetic mice were found (at 6 h or 18 h) in the presence of 20 mM DPI. Mean percent apoptotic
neutrophils 6 SEM from 3 to 6 independent experiments are depicted. P values are calculated from pair-wise comparisons of age-matched mice,
* indicates P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0023633.g005
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8 CFU
S. aureus PS80. (A) Intracellular TNFa staining of neutrophils from a representative age-matched mouse pair 3 h (upper panels) or 10 h (lower
panels) after neutrophil isolation. The upper right panels show the percentage of neutrophils that stained positive for TNFa production. (B) Whereas
no significant differences were found between diabetic and nondiabetic mice after 3 h, diabetic animals had significantly more neutrophils positive
for TNFa 10 h after neutrophil isolation. Data represent means 6 SEM of data from six independent experiments. P values are calculated from pair-
wise comparisons of age-matched mice; * indicates P,0.05.
doi:10.1371/journal.pone.0023633.g006
Figure 7. In vitro phagocytosis of apoptotic neutrophils by murine macrophages. Inflammatory cells were isolated from infected mouse
peritoneal cavities 18 h after IP challenge with 10
8 CFU PS80. The neutrophils were labeled with CellTracker Green, incubated in vitro for 8 h to
induce apoptosis, and incubated with adherent autologous macrophages for 90 min to allow for uptake. (A) Representative image of CellMask
Orange-stained macrophages with phagocytosed neutrophils from an age-matched pair of a diabetic (upper picture) and nondiabetic (lower picture)
control mice. Phagocytosis of apoptotic neutrophils by macrophages from diabetic mice is less than that of macrophages from nondiabetic mice.
Some neutrophils are still extracellular whereas others have been internalized. (B) Macrophages from diabetic mice ingested significantly fewer
neutrophils than macrophages from nondiabetic control mice. Data are means 6 SEM of six independent experiments; * indicates P,0.05.
doi:10.1371/journal.pone.0023633.g007
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The rising prevalence of both type 1 and type 2 diabetes
worldwide [1,2,24] has led to an increasing incidence of diabetes-
associated complications. While intensive research has been
carried out on the epidemiology, pathogenesis and major
complications of diabetes, the pathophysiology of infectious and
inflammatory complications has received less attention. Ketoaci-
dosis in patients with type 1 diabetes is frequently precipitated by
infections [25], and diabetic patients in general are more
susceptible to a variety of infections [26,27], especially those
caused by S. aureus. Diabetic patients have a higher rate of nasal
colonization with S. aureus than healthy controls [28,29], and S.
aureus is frequently isolated from diabetic foot infections, which are
a major cause for hospitalization of diabetic patients [30]. Diabetes
is a risk factor for invasive S. aureus disease [8], including
pneumonia [31]. Moreover, diabetes mellitus is the second most
common underlying comorbidity in S. aureus bacteremia cohorts,
and diabetes is associated with a poorer outcome both in
bacteremia and endocarditis [32–34]. With regard to leukocyte
function in diabetes mellitus, the available data are conflicting.
Whereas some authors report differences in neutrophil metabolism
[35], cytokine production [36], respiratory burst [17] or bacterial
killing [37,38], other studies failed to detect significant reductions
in neutrophil function in diabetic hosts [39]. Delayed healing of
chronic wounds in diabetic hosts has been linked to persistent
inflammation reflected by high neutrophil and macrophage
numbers and elevated levels of proinflammatory cytokines [9,11].
NOD mice spontaneously develop autoimmune diabetes
(resembling type 1 diabetes in humans) and present a valuable
tool to study the pathogenesis of infectious diseases in a diabetic
host. We utilized a mouse model of bacterial peritonitis to measure
recruitment of neutrophils to the site of an invasive S. aureus
infection and to monitor the fate of those neutrophils after
bacterial uptake. Although the immediate influx of neutrophils to
the peritoneal cavity was similar for nondiabetic and diabetic mice,
more neutrophils persisted at the infection site 48 h after challenge
in diabetic mice compared to nondiabetic littermates. This is in
contrast to our findings in a localized S. aureus infection of the
mouse hindpaw in which diabetic mice showed a delayed
inflammatory response in the infected tissue compared to that of
age-matched nondiabetic littermates [17].
In a systemic infection ongoing neutrophil recruitment due to a
higher bacterial burden in the peritoneal cavity of diabetic mice
cannot be reliably distinguished from an increase in neutrophil
half-life. To overcome this dilemma, we collected and evaluated
neutrophils at a time point when cell counts were not significantly
different between diabetic and nondiabetic animals (i.e., 18 h). A
limitation of our approach, however, is that monitoring neutrophil
apoptosis requires an ex vivo experimental design to preclude loss of
apoptotic cells through clearance by macrophages in vivo. There
are likely differences between the conditions of the ex vivo
incubations in comparison to the conditions within the peritoneal
cavity, and such differences could alter the rate of neutrophil
apoptosis.
Neutrophils isolated from the infected peritoneal cavities of
diabetic mice showed prolonged viability ex vivo in trypan blue
exclusion assays compared to that of nondiabetic mice. Neutrophils
are abundant but short lived cells, and constitutive apoptosis is
essential for regulating neutrophil homeostasis [18]. Whereas
constitutive apoptosis can be delayed through extracellular proin-
flammatory agents such as Toll-like receptor agonists [40],
neutrophils undergo rapid apoptosis following phagocytosis of
bacteria [19]. This pathogen-induced cell death is dependent on the
production of neutrophil NADPH-oxidase derived reactive oxygen
species (ROS) without the need for traditional death receptors [41].
ROS generated via the NADPH oxidase are essential for
phosphatidylserine exposure during cell death induced by phorbol
myristate acetate, but not for neutrophils undergoing spontaneous
apoptosis [42]. Likewise, S. aureus induced neutrophil apoptosis is
dose- and time-dependant, mediated by ROS and greatly increased
in the presence of viable staphylococci [43,44]. The fate of
professional phagocytes is modulated depending on the nature of
the bacterial pathogen and the host cell type involved. Whereas
induction of apoptosis in longer lived professional phagocytes (such
as macrophages) may present a way of undermining the host
immune response, neutrophil apoptosis upon phagocytosis of
bacteria seems to be essential for the resolution of infection [45].
S. aureus-infected diabetic mice showed a significantly lower rate
of neutrophil apoptosis than infected nondiabetic littermates at
Figure 8. In vivo phagocytosis of apoptotic neutrophils by murine macrophages. Inflammatory cells were isolated from peritoneal exudates
18 h after IP challenge of NOD mice with 10
8 CFU S. aureus. The neutrophils were labeled with CellTracker Green and injected measured IP into
recipient diabetic or nondiabetic mice that were previously infected with S. aureus. Inflammatory cells from the recipient animals were collected 3 h
later, macrophages were stained with F4/80-PE, and the percentage of macrophage-associated neutrophils was using flow cytometry. A) Flow
cytometric analysis of inflammatory cells from a diabetic and a nondiabetic mouse. Macrophage-associated labeled neutrophils are in the upper right
region; labeled neutrophils not associated with macrophages are depicted in the lower right region. Unlabeled cells from the recipient animals are
depicted in the left regions. B) Significantly fewer neutrophils from diabetic mice were associated with macrophages compared to nondiabetic
controls. The data represent the means 6 SEM of results from six independent experiments; * indicates P,0.05.
doi:10.1371/journal.pone.0023633.g008
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observed in neutrophils elicited by a sterile stimulus, but it was
dependent on the presence of both bacteria and a functional
NADPH oxidase, which is in line with studies by other authors
reporting normal spontaneous apoptosis in neutrophils from
diabetic patients [46]. As studies with S. aureus and neutrophils
from mice with chronic granulomatous disease [21] or mice
lacking beta-integrins [41] have shown, a NADPH-oxidase
deficiency leads to reduced neutrophil apoptosis and elevated
neutrophil numbers in inflammatory exudates, consistent with
impaired recognition and clearance. However, our study demon-
strates that a different disease entity (diabetes) leads to reduced
neutrophil clearance resulting from a moderately reduced ROS
production [17] instead of a complete absence of NADPH oxidase
activity. Neutrophils from the blood of hyperglycemic NOD mice
exhibit a diminished respiratory burst in response to S. aureus [17],
and this may contribute to reduced pathogen-induced apoptosis in
diabetic mice, resulting in higher neutrophil counts in peritoneal
exudate fluids. Clinical studies have found a decreased rate of
neutrophil apoptosis (eventually promoting tissue injury) in a
patient group with major diabetic complications [47]. Previous
studies have focused on the inability of diabetic patients to delay
constitutive apoptosis of neutrophils upon stimulation with LPS
[36,48].
During the induction of apoptosis, neutrophils undergo
significant alterations in gene expression profiles [22], including
several genes encoding inflammatory cytokines. Consistent with
reduced apoptosis, we showed that neutrophils from S. aureus
infected diabetic mice failed to down regulate the production of
TNFa over time. The failure to limit the production of mediators
potentially causing tissue injury might contribute to the extensive
tissue damage observed during infections in diabetic patients.
The clearance of neutrophils and their toxic contents, which
could be deleterious for the surrounding tissue, is an important
prerequisite for the resolution of infection. Neutrophil uptake by
macrophages and their subsequent degradation is an important
means of limiting tissue injury associated with inflammation [20].
Phosphatidylserine is externalized to the outer membrane layer
during apoptosis and participates in neutrophil clearance by
macrophages [49], a process that does not seem to be inhibited by
high concentration of glucose [50]. Without apoptosis, neutrophil
effector function is preserved and internalization by macrophages
is prevented [51]. The ingestion of apoptotic neutrophils not only
leads to the removal of cytotoxic content, but it also modulates the
host immune response [52]. Previous studies have shown that after
neutrophils engulf S. aureus, phosphatidylserine exposure occurs,
resulting in neutrophil uptake by macrophages [21]. We compared
these processes in diabetic and nondiabetic mice both ex vivo and in
vivo. Under both conditions, we observed fewer S. aureus-stimulated
neutrophils within macrophages from diabetic mice than nondi-
abetic mice. Macrophages from 5–6 wk old normoglycemic NOD
mice showed reduced phagocytosis of apoptotic thymocytes when
compared to macrophages from BALB/c mice [53]. However, our
comparisons were made between infected age-matched diabetic
and nondiabetic mice of the same genetic background, and thus
the lower rate of neutrophil clearance by macrophages could be
correlated with the diabetic state of the host. Gresham et al.
showed that S. aureus may survive inside mouse neutrophils in vivo,
and that infected neutrophils were sufficient to establish an
infection when transferred to naı ¨ve animals [54]. Hence,
diminished neutrophil apoptosis after uptake of S. aureus and
subsequent impaired clearance by macrophages may contribute to
the persistent nature of staphylococcal infections observed in
diabetic patients. Our studies suggest that reduced neutrophil
apoptosis contributes to the chronic inflammation, extensive tissue
injury and persistent staphylococcal infections observed in diabetic
hosts.
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